Stephan Weber serves as the Executive Director of Global Program Management in the Gastroenterology & Immunology Therapeutic Area at Takeda, where he leverages over 20 years of extensive international experience to spearhead high-impact initiatives. In his current role, Stephan is instrumental in leading a flagship...
Stephan Weber serves as the Executive Director of Global Program Management in the Gastroenterology & Immunology Therapeutic Area at Takeda, where he leverages over 20 years of extensive international experience to spearhead high-impact initiatives. In his current role, Stephan is instrumental in leading a flagship program that spans multiple indications, coordinating efforts across global, cross-functional, and cross-divisional teams. His expertise in project portfolio management and regulatory affairs enables him to navigate the complexities of drug development while ensuring compliance with stringent industry standards.
Stephan's strategic vision is a cornerstone of his leadership style, allowing him to craft and execute comprehensive business plans that align with Takeda's mission to deliver innovative therapies. He adeptly manages intense organizational scrutiny, driving development timelines and delivering results that meet or exceed expectations. His certifications, including Project Management Associate from IPMA and Biotechnology Project Management from MIT, underscore his commitment to excellence in project leadership and operational efficiency.
Key projects under Stephan's guidance often involve the integration of cutting-edge biotechnology solutions to address unmet medical needs in gastroenterology and immunology. His collaborative approach fosters a culture of innovation, empowering cross-functional teams to adapt swiftly to the fast-paced pharmaceutical landscape. With a proven track record in clinical research and monitoring, Stephan continues to be a pivotal figure in advancing Takeda's therapeutic portfolio, ultimately contributing to improved patient outcomes worldwide.
